Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia (scientific article published on 17 August 2011)

Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses

Q30990507

An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.

Q33221698

Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension

Q33436692

First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies

Q33633599

The apoptosis cascade--morphological and immunohistochemical methods for its visualization

Q33680390

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

Q33755648

Oxygen and placental vascular development

Q33817317

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

Q33947553

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

Q33990220

Maternal and neonatal outcome in early- and late-onset pre-eclampsia

Q34012733

Placental debris, oxidative stress and pre-eclampsia

Q34032003

Is 'pre-eclampsia' simply a response to the side effects of a placental tachykinin?

Q34104278

Placental-specific IGF-II is a major modulator of placental and fetal growth.

Q34135795

Retinol binding protein 4--a novel association with early-onset preeclampsia

Q34234671

The pathogenesis of pre-eclampsia

Q34383374

Latest advances in understanding preeclampsia

Q34425288

Vitamins C and E and the risks of preeclampsia and perinatal complications

Q34518082

Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort

Q34567015

Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction.

Q34702420

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

Q34708320

Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae

Q34975562

Second-trimester uterine artery Doppler screening in unselected populations: a review

Q34991366

Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia.

Q35096089

Maternal serum adiponectin multimers in preeclampsia

Q35194054

Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia

Q78400398

Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells

Q78423680

Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae

Q78881775

First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia

Q79409207

Is pre-eclampsia more than one disease?

Q79752866

Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age

Q80609401

Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature

Q81423834

Analysis of plasma elastase levels in early and late onset preeclampsia

Q81489446

A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound

Q82068160

Doppler sonography of the uterine and the cubital arteries in normal pregnancies, preeclampsia and intrauterine growth restriction: evidence for a systemic vessel involvement

Q82741244

Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy

Q83212142

Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women

Q84689681

Are early and late preeclampsia distinct subclasses of the disease--what does the placenta reveal?

Q84719522

Hypertension induced by episodic reductions in uteroplacental blood flow in gravid rat

Q85038962

Subclassification of preeclampsia

Q35196220

Biological implications of bi-directional fetomaternal cell traffic: a summary of a National Institute of Child Health and Human Development-sponsored conference.

Q35589383

Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods

Q35886564

The "Great Obstetrical Syndromes" are associated with disorders of deep placentation

Q36015615

Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis

Q36050839

Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate

Q36145631

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

Q36189562

A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia

Q36221448

STUDIES ON EXPERIMENTAL HYPERTENSION : IX. THE EFFECT ON BLOOD PRESSURE OF CONSTRICTION OF THE ABDOMINAL AORTA ABOVE AND BELOW THE SITE OF ORIGIN OF BOTH MAIN RENAL ARTERIES.

Q36257296

The role of Fas mediated apoptosis in preeclampsia

Q36327217

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

Q36360704

Preeclampsia as a cause of preterm and late preterm (near-term) births

Q36426156

Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia

Q36512059

Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies

Q36512063

Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia

Q36524450

Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Q36560160

First trimester screening for preeclampsia

Q36651214

Preeclampsia is associated with low concentrations of protein Z.

Q36670687

Normal and abnormal transformation of the spiral arteries during pregnancy.

Q36670865

Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed.

Q36701110

Adiponectin in severe preeclampsia.

Q36946738

Prediction of preeclampsia - a workshop report

Q36968505

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

Q36984261

Genes and the preeclampsia syndrome

Q37053831

The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia

Q37088970

Hypertensive disorders of pregnancy: the United States perspective

Q37128585

Advances in the understanding of eclampsia

Q37215562

Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia

Q37421465

Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.

Q37428029

First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Q37444801

Pre-eclampsia and expression of heparin-binding EGF-like growth factor.

Q38454644

Long-term mortality after preeclampsia

Q38475210

Toxemia: new concepts in an old disease

Q39559348

Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction

Q40238276

Intra- and interobserver agreement and statistical clustering of placental histopathologic features relevant to preterm birth

Q40313051

Placental pathologic features of preterm preeclampsia.

Q40373889

Neonatal outcome after preterm delivery for preeclampsia

Q40543077

Preeclampsia: an excessive maternal inflammatory response to pregnancy

Q40824430

Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives

Q40959095

Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives

Q41084946

Preeclampsia: an endothelial cell disorder

Q41281924

Placental cytokines and the pathogenesis of preeclampsia

Q41452017

Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia

Q42511665

Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome

Q43157207

Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia

Q43291300

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

Q43991495

Placental bed spiral arteries in the hypertensive disorders of pregnancy

Q44053736

A longitudinal study of biochemical variables in women at risk of preeclampsia

Q44062096

Genome profiles in maternal blood during early onset preeclampsia and towards term

Q44692373

Hemodynamic studies in experimental toxemia of the dog

Q45163024

A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000

Q45210774

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks

Q46321423

Ischemic placental disease: maternal versus fetal clinical presentations by gestational age.

Q46332690

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

Q46339760

Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes

Q46340423

Impact of preeclampsia and gestational hypertension on birth weight by gestational age.

Q47194029

Circulating angiogenic factors and the risk of preeclampsia

Q47217679

Three-dimensional spheroidal culture of cytotrophoblast cells mimics the phenotype and differentiation of cytotrophoblasts from normal and preeclamptic pregnancies

Q47304098

The frequency and severity of placental findings in women with preeclampsia are gestational age dependent

Q47414750

Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia

Q47674689

Endothelial dysfunction in preeclampsia

Q47879591

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

Q48348609

Prenatal medicine: the child is the father of the man. 1996.

Q48480846

Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.

Q50734891

Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats.

Q50952787

Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.

Q51766121

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

Q51794305

Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach.

Q51822307

Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia.

Q52009983

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

Q52237839

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Q53600812

The comparison of uterine artery Doppler velocimetry with the histopathology of the placental bed.

Q54072954

Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis).

Q54452496

Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants.

Q54741234

Placental stress and pre-eclampsia: a revised view.

Q54774592

A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation

Q56444585

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

Q57316937

Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction

Q57316953

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

Q57408925

Aspirin and Prevention of Preeclampsia

Q57670648

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

Q58377198

Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death

Q58417742

Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death

Q58417749

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

Q58778301

Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies?

Q59437931

Placental diagnostic criteria and clinical correlation – a workshop report

Q59662967

Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks

Q61826545

Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia

Q61845360

Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin

Q61845423

Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia

Q61845530

Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

Q61845775

Clinical significance of liver dysfunction in pregnancy-induced hypertension

Q61845930

Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births

Q61847698

First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia

Q61848183

Early and Late Preeclampsia

Q61853974

Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta

Q61865493

Preeclampsia and fetal growth

Q61911566

Comparison of uteroplacental blood flow in normal and in intrauterine growth-retarded pregnancy. Measurements with Indium-113m and a computer-linked gammacamera

Q66993110

Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency

Q68013154

Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera

Q70634226

Placental infarction and toxemia of pregnancy

Q71098256

Uteroplacental blood flow index in intrauterine growth retardation of fetal or maternal origin

Q71651233

The placenta in acute toxemia. A comparative study

Q72101798

New doppler technique for assessing uteroplacental blood flow

Q72548759

Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia

Q73078525

Risk factors and clinical manifestations of pre-eclampsia

Q73299051

Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro

Q73314016

Histomorphology of the Placenta and the Placental Bed of Growth Restricted Foetuses and Correlation with the Doppler Velocimetries of the Uterine and Umbilical Arteries

Q73389386

Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery

Q73407051

Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation

Q73598093

Decreased maternal serum placenta growth factor in early second trimester and preeclampsia

Q73953218

Expression of inflammatory cytokines in placentas from women with preeclampsia

Q73992120

Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies

Q74731060

Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation

Q77637958

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

pre-eclampsia

Q61335

P304

page(s)

641-652

P577

publication date

2011-08-17

P1433

published in

Journal of Perinatal Medicine

Q15753400

P1476

title

Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia

P478

volume

Reverse relations

cites work (P2860)

Q53639289	Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.
Q41043453	Acute Kidney Injury in Pregnancy-specific Disorders
Q35104545	Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia
Q38193203	Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?
Q36055507	Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia
Q36357099	Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
Q47634764	Body mass index and the risk of hypertensive disorders of pregnancy: the great obstetrical syndromes (GOS) study
Q57316852	Can prenatal screening reduce the adverse obstetric outcomes related to abnormal placentation?
Q38213813	Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review
Q47949514	Cardiac diastolic function after recovery from pre-eclampsia
Q37612423	Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome
Q43637985	Clinicoplacental phenotypes vary with gestational age: an analysis by classical and clustering methods
Q47562332	Comparative Study of Abdominal Versus Transvaginal Ultrasound for Uterine Artery Doppler Velocimetry at 11 to 13 Weeks.
Q35187773	Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary
Q34182374	Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa
Q90683764	Differences in expression of Peroxisome Proliferator-activated Receptor-γ in early-onset preeclampsia and late-onset preeclampsia
Q34777981	Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia
Q51802500	Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia?
Q22306400	Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis
Q35885455	Effect of Placenta Previa on Preeclampsia
Q55020510	Evaluation of circulating placenta-related long noncoding RNAs as potential biomarkers for preeclampsia.
Q34372600	Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia
Q45328904	First-trimester metabolomic detection of late-onset preeclampsia
Q35362708	Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice
Q48238324	High normal blood pressure in early pregnancy also contribute to early onset preeclampsia and severe preeclampsia
Q34505704	In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy
Q36615134	Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1
Q47143920	Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.
Q58795465	Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia
Q36107337	Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion
Q41033848	Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study
Q34619975	Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.
Q55004295	Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.
Q33909572	Maternal plasma soluble TRAIL is decreased in preeclampsia
Q40367971	Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study
Q38814012	Maternal vascular malperfusion of the placental bed associated with hypertensive disorders in the Boston Birth Cohort
Q41230298	Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes
Q36901534	Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.
Q26861380	Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy
Q38823706	Placental histopathology associated with preeclampsia: A systematic review and Meta-Analysis
Q35558666	Placental lesions associated with acute atherosis
Q35058774	Placental maturity, hypertensive disorders of pregnancy and birth weight.
Q46302359	Placental pathology varies in hypertensive conditions of pregnancy
Q52929936	Placental syndromes: getting to the heart of the matter.
Q34568696	Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.
Q38085776	Placental vascular pathology as a mechanism of disease in pregnancy complications
Q34119026	Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study
Q92903848	Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia
Q33625295	Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from preeclamptic pregnancies.
Q33416340	Pre-eclampsia part 1: current understanding of its pathophysiology
Q57177277	Preeclampsia and Related Cardiovascular Risk: Common Genetic Background
Q46315908	Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia
Q103001912	Pregnant alpha-1-microglobulin (A1M) knockout mice exhibit features of kidney and placental damage, hemodynamic changes and intrauterine growth restriction
Q34200215	Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation
Q26781800	Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis
Q34506462	Protein profiling of preeclampsia placental tissues
Q47822335	Retained placenta is associated with pre-eclampsia, stillbirth, giving birth to a small-for-gestational-age infant, and spontaneous preterm birth: a national register-based study.
Q64124378	Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation
Q30276543	Stillbirth, hypertensive disorders of pregnancy, and placental pathology
Q92922249	The Difference in Maternal Serum Hypoxia-Inducible Factors-1α Levels between Early Onset and Late-Onset Preeclampsia
Q52715243	The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.
Q34150192	The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia
Q61844931	The frequency and type of placental histologic lesions in term pregnancies with normal outcome
Q35593888	The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion
Q92515855	The prediction of early preeclampsia: Results from a longitudinal proteomics study
Q38664824	The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study
Q50102668	The profiles of soluble adhesion molecules in the "great obstetrical syndromes".
Q36173660	Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion.
Q47187556	Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia
Q38990948	Validation of metabolomic models for prediction of early-onset preeclampsia
Q50507287	[Pathoanatomical and clinical aspects of the placenta in preterm birth].